Stimulation of maxi-K channels in trabecular meshwork by tyrosine kinase inhibitors

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 7, 1999, Pages 1404-1417

  Stumpff, Friederike ^a   Que, Yang ^b   Boxberger, Marianne ^b   Strauss, Olaf ^b   Wiederholt, Michael ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; POTASSIUM CHANNEL; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CATTLE; GLAUCOMA; HYPERPOLARIZATION; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; TRABECULAR MESHWORK;

ACETYLCHOLINE; ANIMALS; CALCIUM; CATTLE; CELLS, CULTURED; CHARYBDOTOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTEIN-TYROSINE KINASES; TETRAETHYLAMMONIUM; TRABECULAR MESHWORK;

EID: 0033044155     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Wiederholt M, Stumpff F. The trabecular meshwork and aqueous humor reabsorption. Curr Top Membr. 1998;45:163-202.
2. Lepple-Wienhues A, Stahl F, Wiederholt M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp Eye Res. 1991;53:33-38.
3. Wiederholt M, Bielka S, Schweig F, Lütjen-Drecoll E, Lepple-Wienhues A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res. 1995; 61:223-234.
4. Davies DE, Chamberlin SG. Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochem Pharmacol. 1996; 51:1101-1110.
5. Boutin JA. Tyrosine protein kinase inhibition and cancer. Int J Biochem. 1994;26:1203-1226.
6. Levitzki A. Signal-transduction therapy: a novel approach to disease management. EurJ Biochem. 1994;226:1-13.
7. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267:1782-1788.
8. Wiederholt M, Groth J, Strauss O. Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility. Invest Ophthalmol Vis Sci. 1998;39:1012-1020.
9. + currents by tyrosine kinase inhibitors genistein and ST 638. Circ Res. 1995;76:310-316.
10. Hollenberg MD. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci. 1994;15:108-114.
11. Malarkey K, Belham CM, Paul A, et al. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J. 1995;309:361-375.
12. Russell M, Hoeffler JP. Signal transduction and the regulation of cell growth. J Invest Dermatol Symp Proc. 1996;1:119-122.
13. Di Salvo J, Nelson SR, Kaplan N. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc Soc Exp Biol Med. 1997;214:285-301.
14. Strauss O, Mergler S, Wiederholt M. Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells. FASEB J. 1997;11:859-867.
15. Prevarskaya NB, Skryma RN, Vacher P, Daniel N, Djiane J, Dufy B. Role of tyrosine phosphorylation in potassium channel activation: functional association with prolactin receptor and JAK2 tyrosine kinase. J Biol Cbem. 1995;270:24292-24299.
16. Liu H, Li K, Sperelakis N. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can J Physiol Pharmacol. 1997;75:1058-1062.
17. Coroneo MT, Korbmacher C, Flügel C, Stiemer B, Lütjen-Drecoll E, Wiederholt M. Electrical and morphological evidence for heterogeneous populations of cultured bovine trabecular meshwork cells. Exp Eye Res. 1991;52:375-388.
18. Lepple-Wienhues A, Stahl F, Wunderling D, Wiederholt M. Effects of endothelin and calcium channel blockers on membrane voltage and intracellular calcium in cultured bovine trabecular meshwork cells. Ger J Ophthalmol. 1992;1:159-163.
19. Anderson PJ, Wang J, Epstein DL. Metabolism of calf trabecular (reticular) meshwork. Invest Ophthalmol Vis Sci. 1980;19:13-20.
20. Tripathi RC, Tripathi BJ. Human trabecular endothelium, corneal endothelium, keratocytes, and scleral fibroblasts in primary cell culture: a comparative study of growth characteristics, morphology, and phagocytic activity by light and scanning electron microscopy. Exp Eye Res 1982;35:611-624.
21. Stumpff F, Strauss O, Boxberger M, Wiederholt M. Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate. Invest Ophthalmol Vis Sci. 1997;38:1883-1892.
22. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92: 145-159.
23. Neher E. Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol. 1992;207:123-131.
24. Neher E. The influence of intracellular calcium concentration on degranulation of dialysed mast cells from rat peritoneum. J Physiol Lond. 1988;395:193-214.
25. Kunzelmann K, Pavenstadt H, Greger R. Characterization of potassium channels in respiratory cells, II: inhibitors and regulation. Pflugers Arch. 1989;414:297-303.
26. Ramanan SV, Brink PR. Alternate methods of representing single-channel data. Biophys J. 1990;57:893-901.
27. Wiederholt M, Schäfer R, Wagner U, Lepple-Wienhues A. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger J Ophthalmol. 1996; 5:146-153.
28. Gribkoff VK, Lum-Ragan JT, Boissard CG, et al. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol Pharmacol. 1996;50:206-217.
29. Kirischuk S, Scherer J, Kettenmann H, Verkhratsky A. Activation of P2-purinoreceptors triggered Ca2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J Physiol (Lond). 1995;483:41-57.
30. Cataldi M, Taglialatela M, Guerriero S, et al. Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. J Biol Chem. 1996;271:9441-9446.
31. +)-activated K+ channel activity by tyrosine kinase inhibitors in vascular smooth muscle cell. Eur J Pharmacol. 1995;290:117-123.
32. Wijetunge S, Hughes AD. pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun. 1995;217:1039-1044.
33. Pfeiffer N. Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor. Surv Ophthalmol. 1997;42: 137-151.
34. 2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells. J Clin Invest. 1996;97: 2332-2341.
35. Gilabert R, Gasull X, Pales J, et al. Facility changes mediated by cAMP in the bovine anterior segment in vitro. Vision Res. 1997; 37:9-15.
36. Kawa JE, Higginbotham EJ, Chang IL, Yue BY. Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro. Exp Eye Res. 1993;57:557-565.
37. Lepple-Wienhues A, Rauch R, Clark AF, Grässmann A, Berweck S, Wiederholt M. Electrophysiological properties of cultured human trabecular meshwork cells. Exp Eye Res. 1994;59:305-311.
38. Wiederholt M, Sturm A, Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:2515-2520.
39. Gabelt BT, Wiederholt M, Clark AF, Kaufman PL. Anterior segment physiology after bumetanide inhibition of Na-K-Cl cotransport. Invest Ophthalmol Vis Sci. 1997;38:1700-1707.
40. i and pHi in trabecular meshwork cells. Curr Eye Res. 1994;13:197-202.
41. Shade DL, Clark AF, Pang IH. Effects of muscarinic agents on cultured human trabecular meshwork cells. Exp Eye Res. 1996;62: 201-210.
42. Llobet A, Gasull X, Canals L, Nicolas JM, Gual A. Bradykinin effects on trabecular meshwork cells [ARVO Abstract). Invest Ophthalmol Vis Sci. 1998;39(4):S799. Abstract nr 3700.
43. Tamm ER, Siegner A, Baur A, Lütjen-Drecoll E. Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res. 1996;62:389-397.
44. Flügel C, Tamm E, Lütjen-Drecoll E. Different cell populations in bovine trabecular meshwork: an ultrastructural and immunocytochemical study. Exp Eye Res. 1991;52:681-690.
45. Tian B, Kaufman PL, Volberg T, Gabelt BT, Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol. 1998;116:633-643.
46. Gills JP, Roberts BC, Epstein DL. Microtubule disruption leads to cellular contraction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:653-658.
47. Gazit A, Yaish P, Gilon C, Levitzki A. Tyrphostins, I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem. 1989;32:2344-2352.
48. Hollenberg MD. Tyrosine kinase-mediated signal transduction pathways and the actions of polypeptide growth factors and G-protein-coupled agonists in smooth muscle. Mol Cell Biochem. 1995;149-150:77-85.
49. Srivastava AK, St-Louis J. Smooth muscle contractility and protein tyrosine phosphorylation. Mol Cell Biochem. 1997;176:47-51.
50. Chiang CE, Chen SA, Chang MS, Lin CI, Luk HN. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochem Biophys Res Commun. 1996;223:598-603.
51. Minami K, Fukuzawa K, Inoue I. Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase. Pflugers Arch. 1994;426:254-257.
52. + channels in rabbit portal vein smooth muscle. Br J Pharmacol. 1997;122:1395-1404.
53. Zhou YY, Yao JA, Tseng GN. Role of tyrosine kinase activity in cardiac slow delayed rectifier channel modulation by cell swelling. Pflugers Arch. 1997;433:750-757.
54. + channel activity in rat ventricular myocytes by phosphorylation of tyrosine and serine/threonine residues. Life Sci. 1996;58:897-904.
55. Holmes TC, Fadool DA, Levitan IB. Tyrosine phosphorylation of the Kv1.3 potassium channel. J Neurosci. 1996;16:1581-1590.
56. Nelson MT, Cheng H, Rubart M, et al. Relaxation of arterial smooth muscle by calcium sparks (see comments). Science. 1995;270: 633-637.
57. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799-C822.
58. Holmes TC, Fadool DA, Ren R, Levitan IB. Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain. Science. 1996;274:2089-2091.
59. Chandy KG, Gutman GA. Voltage gated potassium channel genes. In: North RA, ed. Handbook of Receptors and Channels, Ligand and Voltage Gated Ion Channels. Boca Raton, FL: CRC Press; 1995:1-71.
60. Kaczorowski GJ, Knaus HG, Leonard RJ, McManus OB, Garcia ML. High-conductance calcium-activated potassium channels: structure, pharmacology, and function. J Bioenerg Biomembr. 1996; 28:255-267.
61. Brayden JE. Potassium channels in vascular smooth muscle. Clin Exp Pharmacol Physiol. 1996;23:1069-1076.
62. Kotlikoff MI, Kamm KE. Molecular mechanisms of beta-adrenergic relaxation of airway smooth muscle. Annu Rev Physiol. 1996;58: 115-141.
63. 2+ /calmodulin-dependent myosin light-chain kinases. Adv Second Messenger Phosphoprotein Res. 1997;31:141-150.
64. Craig R, Smith R, Kendrick-Jones J. Light-chain phosphorylation controls the conformation of vertebrate non-muscle and smooth muscle myosin molecules. Nature. 1983;302:436-439.
65. de Kater AW, Shahsafaei A, Epstein DL. Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1992;33:424-429.
66. de Kater AW, Spurr-Michaud SJ, Gipson IK. Localization of smooth muscle myosin-containing cells in the aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1990;31:347-353.
67. 2+ homeostasis in vascular smooth muscle. J Vasc Res. 1995;32:207-219.
68. Howlett SE, Ferrier GR. The Merck Frosst Award. The voltage-sensitive release mechanism: a new trigger for cardiac contraction. Can J Physiol Pharmacol. 1997;1996:75:1044-1057.
69. Walker LA, Gailly P, Jensen PE, Somlyo AV, Somlyo AP. The unimportance of being (protein kinase C) epsilon. FASEB J. 1998; 12:813-821.
70. 2+)-independent contractions of vascular smooth muscle. Biochem Cell Biol. 1996;74:485-502.
71. Lepple-Wienhues A, Stahl F, Willner U, Schafer R, Wiederholt M. Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork: interaction with calcium, nifedipine and nickel. Curr Eye Res. 1991;10:983-989.